Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 4c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.32), $0.04 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
• Increasing unusual put option volume: OSS CTSH PZZA BFLY CDNS WMB KD DFTX CAN HIVE SOC WYFI SIMO